A 2-year-old girl with Stevens-Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin

Pediatric Dermatology

Volumn 22, Issue 4, 2005, Pages 317-320

  Arca, Ercan ^a   Köse, Osman ^a   Erbil, A Hakan ^a   Nişanci, Mustafa ^a   Akar, Ahmet ^a   Gür, Ali Riza ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; CORTICOSTEROID; FUSIDIC ACID; IMIPENEM; IMMUNOGLOBULIN; NYSTATIN; SULTAMICILLIN;

ANAMNESIS; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; DEBRIDEMENT; DRUG ERUPTION; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; LABORATORY TEST; PARENTERAL NUTRITION; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN BIOPSY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

AMPICILLIN; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; RESPIRATORY TRACT INFECTIONS; STEVENS-JOHNSON SYNDROME; SULBACTAM;

EID: 27744527570     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2005.22407.x     Document Type: Article

References (24)

1. Wong KC, Kennedy PJ, Lee S. Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis. Austral J Dermatol 1999;40:131-134.
2. Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. A prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 2003;139:33-36.
3. Auquer-Dunant A, Mochenhaupt M, Naldi L, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnsons syndrome, and toxic epidermal necrolysis. Arch Dermatol 2002;138:1019-1024.
4. Garcia-Doval I, LeCleach L, Bocquet H, et al. Toxic epidermal necrolysis and Stevens-Johnson syndome. Arch Dermatol 2000;136:323-327.
5. Halevy S, Cohen AD, Livni E. The diagnostic role of the in vitro drug-induced interferon-α release test in Stevens-Johnson syndrome. Int J Dermatol 1999;38:835-840.
6. Samimi SS, Siegfried E. Stevens-Johnson syndrome developing in a girl with systemic lupus erythematous on high-dose corticosteroid therapy. Pediatr Dermatol 2002;19:52-55.
7. Trent JT, Kirsner RS, Romanelli P, et al. Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN. Arch Dermatol 2003;139:39-43.
8. Tristani-Firouzi P, Petersen MJ, Saffle JR, et al. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol 2002;47:548-552.
9. Atiyeh BS, Dham R, Yassin MF, et al. Treatment of toxic epidermal necrolysis with moisture-retentive ointment: a case report and review of the literature. Dermatol Surg 2003;29:185-188.
10. Sanclemente G, De la Roche CA, Escobar CE, et al. Pentoxifylline in toxic epidermal necrolysis and Stevens-Johnsons syndrome. Int J Dermatol 1998;38:878-879.
11. Prins C, Kerdel AF, Padilla RS, et al. Treatment toxic epidermal necrolysis with high-dose intravenous immunoglobulins. Arch Dermatol 2003;139:26-32.
12. Paul C, Wolkenstein P, Adle H, et al. Apoptosis as a mechanics of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996;134:710-714.
13. Ringheanu M, Laude TA. Toxic epidermal necrolysis in children: an update. Clin Pediatr 2000;39:687-694.
14. Stern RS. Improving the outcome of patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch Dermatol 2000;136:410-411.
15. Pasricha JS, Khaitan BK, Shantharaman R, et al. Toxic epidermal necrolysis. Int J Dermatol 1996;35:523-527.
16. Spies M, Sanford AP, Aili Low JF, et al. Treatment of extensive toxic epidermal necrolysis in children. Pediatrics 2001;108:1162-1169.
17. Davis MDP, Rogers RS, III, Pittelkow MR. Recurrent erythema multiforme/Stevens-Johnson syndrome: response to mycophenolate mofetil. Arch Dermatol 2002;138:1547-1550.
18. Van der Meer JB, Schuttelaar MLA, Toth GG, et al. Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam. Clin Exp Dermatol 2001;26:654-656.
19. Yalçin B, Karaduman A. Stevens-Johnson syndrome associated with concomitant use of lamotrigine and valproic acid. J Am Acad Dermatol 2000;43:898-899.
20. Magina S, Lisboa C, Goncalves E, et al. A case of toxic epidermal necrolysis treated with intravenous immunoglobulin. Br J Dermatol 2000;142:191-192.
21. Mayorga C, Torres MJ, Corzo JL, et al. Improvement of toxic epidermal necrolysis after early administration of a single high dose of intravenous immunoglobulin. Ann Allergy Asthma Immunol 2003;91:86-91.
22. Tan A, Tan HH, Lee CC, et al. Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins. Clin Exp Dermatol 2003;28:269-271.
23. Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115:149-153.
24. Wollf K, Tappeiner G. Treatment of toxic epidermal necrolysis: the uncertainty persists but the fog is dispersing. Arch Dermatol 2003;139:85-86.